MEDP vs. CPRX
Compare and contrast key facts about Medpace Holdings, Inc. (MEDP) and Catalyst Pharmaceuticals, Inc. (CPRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MEDP or CPRX.
Correlation
The correlation between MEDP and CPRX is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MEDP vs. CPRX - Performance Comparison
Loading data...
Key characteristics
MEDP:
-0.51
CPRX:
1.19
MEDP:
-0.49
CPRX:
1.95
MEDP:
0.93
CPRX:
1.22
MEDP:
-0.59
CPRX:
1.65
MEDP:
-0.97
CPRX:
6.46
MEDP:
24.11%
CPRX:
7.40%
MEDP:
43.74%
CPRX:
41.35%
MEDP:
-42.87%
CPRX:
-94.25%
MEDP:
-33.16%
CPRX:
-5.32%
Fundamentals
MEDP:
$8.79B
CPRX:
$2.97B
MEDP:
$13.11
CPRX:
$1.57
MEDP:
23.32
CPRX:
15.52
MEDP:
3.51
CPRX:
0.00
MEDP:
4.07
CPRX:
5.56
MEDP:
14.80
CPRX:
3.65
MEDP:
$2.16B
CPRX:
$534.65M
MEDP:
$672.28M
CPRX:
$441.72M
MEDP:
$484.51M
CPRX:
$250.28M
Returns By Period
In the year-to-date period, MEDP achieves a -8.00% return, which is significantly lower than CPRX's 16.77% return.
MEDP
-8.00%
3.17%
-1.60%
-22.28%
28.67%
N/A
CPRX
16.77%
8.21%
18.30%
47.79%
40.03%
19.87%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MEDP vs. CPRX — Risk-Adjusted Performance Rank
MEDP
CPRX
MEDP vs. CPRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MEDP vs. CPRX - Dividend Comparison
Neither MEDP nor CPRX has paid dividends to shareholders.
Drawdowns
MEDP vs. CPRX - Drawdown Comparison
The maximum MEDP drawdown since its inception was -42.87%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for MEDP and CPRX. For additional features, visit the drawdowns tool.
Loading data...
Volatility
MEDP vs. CPRX - Volatility Comparison
Medpace Holdings, Inc. (MEDP) has a higher volatility of 13.42% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 10.00%. This indicates that MEDP's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
MEDP vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Medpace Holdings, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MEDP vs. CPRX - Profitability Comparison
MEDP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported a gross profit of 178.35M and revenue of 558.57M. Therefore, the gross margin over that period was 31.9%.
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a gross profit of 123.51M and revenue of 141.42M. Therefore, the gross margin over that period was 87.3%.
MEDP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported an operating income of 113.52M and revenue of 558.57M, resulting in an operating margin of 20.3%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported an operating income of 63.37M and revenue of 141.42M, resulting in an operating margin of 44.8%.
MEDP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Medpace Holdings, Inc. reported a net income of 114.60M and revenue of 558.57M, resulting in a net margin of 20.5%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a net income of 56.74M and revenue of 141.42M, resulting in a net margin of 40.1%.